comparemela.com

Latest Breaking News On - Rad laboratories trading down - Page 4 : comparemela.com

Bio-Rad Laboratories, Inc (NYSE:BIO) Short Interest Update

Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) was the recipient of a significant drop in short interest in June. As of June 15th, there was short interest totalling 281,400 shares, a drop of 26.7% from the May 31st total of 383,800 shares. Currently, 1.3% of the shares of the stock are short sold. Based on […]

City Holding Co Has $663,000 Position in Bio-Rad Laboratories, Inc (NYSE:BIO)

City Holding Co. lifted its stake in Bio-Rad Laboratories, Inc. (NYSE:BIO – Get Rating) by 9.1% during the first quarter, HoldingsChannel reports. The fund owned 1,385 shares of the medical research company’s stock after purchasing an additional 115 shares during the quarter. City Holding Co.’s holdings in Bio-Rad Laboratories were worth $663,000 as of its […]

Bio-Rad Laboratories (NYSE:BIO B) Hits New 12-Month Low at $365 50

Bio-Rad Laboratories, Inc. (NYSE:BIO.B – Get Rating) hit a new 52-week low during mid-day trading on Monday . The stock traded as low as $365.50 and last traded at $365.50, with a volume of 32 shares changing hands. The stock had previously closed at $371.10. Analysts Set New Price Targets Separately, TheStreet upgraded shares of […]

FORA Capital LLC Increases Stake in Bio-Rad Laboratories, Inc (NYSE:BIO)

FORA Capital LLC raised its holdings in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO – Get Rating) by 34.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,569 shares of the medical research company’s stock after buying an additional 400 shares during […]

Toronto Dominion Bank Acquires 1,830 Shares of Bio-Rad Laboratories, Inc (NYSE:BIO)

Toronto Dominion Bank increased its holdings in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO – Get Rating) by 18.1% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 11,917 shares of the medical research company’s stock after purchasing an additional 1,830 shares during the period. […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.